Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Prelude Therapeutics (PRLD)

  • Technical Exchange News
  • Sept. 20, 2025, 01:35 UTC
  • 59
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

LakeShore Biopharma Co., Ltd (LSB)

  • Technical Exchange News
  • Sept. 20, 2025, 01:35 UTC
  • 61
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Prelude Therapeutics (PRLD)

  • Technical Exchange News
  • Sept. 19, 2025, 19:30 UTC
  • 61
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

LakeShore Biopharma Co., Ltd (LSB)

  • Technical Exchange News
  • Sept. 19, 2025, 19:30 UTC
  • 57
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

VYNE Therapeutics Inc. (VYNE)

  • Technical Exchange News
  • Sept. 19, 2025, 01:44 UTC
  • 61
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

LakeShore Biopharma Co., Ltd (LSB)

  • Technical Exchange News
  • Sept. 19, 2025, 01:44 UTC
  • 60
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

VYNE Therapeutics Inc. (VYNE)

  • Technical Exchange News
  • Sept. 18, 2025, 18:46 UTC
  • 59
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

LakeShore Biopharma Co., Ltd (LSB)

  • Technical Exchange News
  • Sept. 18, 2025, 18:46 UTC
  • 58
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

HilleVax Inc. (HLVX)

  • Technical Exchange News
  • Sept. 18, 2025, 08:13 UTC
  • 46
  • 0 comments

HilleVax Inc. (HLVX) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

HilleVax Inc. (HLVX)

  • Technical Exchange News
  • Sept. 18, 2025, 07:19 UTC
  • 47
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: HilleVax, Inc. - Common Stock.

Comment Full text
  • Previous
  • 127
  • 128
  • 129
  • 130
  • 131
  • Next

Search

News categories

  • Technical Exchange News(11356)
  • Event(2790)
  • SEC News(205433)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(134141)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin